Organon (OGN) Goodwill & Intangibles (2020 - 2026)
Organon (OGN) posted quarterly Goodwill & Intangibles of $5.3 billion for Q2 2026, down 12.86% year-over-year from $6.0 billion in Q2 2025, and little changed on a QoQ basis from $5.3 billion in Q1 2026.
Organon (OGN) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Organon has reported Goodwill & Intangibles for 7 years, with the latest figure at $5.3 billion in Q2 2026.
- Goodwill & Intangibles for Q2 2026 came in at $5.3 billion, down 12.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.3 billion (down 12.86% YoY), and the FY2025 annual result was $5.3 billion, down 13.31% from the prior year.
- Goodwill & Intangibles steadied at $5.3 billion in Q2 2026, from $5.3 billion in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $29.1 billion in Q4 2023 and troughed at $4.7 billion in Q3 2025.
- A 5-year average of $6.6 billion and a median of $5.3 billion in 2022 frame the typical range for Goodwill & Intangibles.
- The widest annual swing landed in 2023, when Goodwill & Intangibles soared 454.53%; it then tumbled 79.08% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $5.3 billion in 2022, then soared by 454.53% to $29.1 billion in 2023, then tumbled by 79.08% to $6.1 billion in 2024, then dropped by 13.31% to $5.3 billion in 2025, then dropped by 0.34% to $5.3 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $5.3 billion in Q2 2026, $5.3 billion in Q1 2026, and $5.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.27 Bn |
| Mar 31, 2026 | 5.25 Bn |
| Dec 31, 2025 | 5.28 Bn |
| Sep 30, 2025 | 4.71 Bn |
| Jun 30, 2025 | 6.04 Bn |
| Mar 31, 2025 | 4.73 Bn |
| Dec 31, 2024 | 6.09 Bn |
| Sep 30, 2024 | 4.72 Bn |
| Jun 30, 2024 | 5.29 Bn |
| Mar 31, 2024 | 4.82 Bn |
| Dec 31, 2023 | 5.14 Bn |
| Sep 30, 2023 | 5.16 Bn |
| Jun 30, 2023 | 5.20 Bn |
| Mar 31, 2023 | 5.22 Bn |
| Dec 31, 2022 | 5.25 Bn |
| Sep 30, 2022 | 5.27 Bn |
| Jun 30, 2022 | 5.24 Bn |
| Mar 31, 2022 | 5.27 Bn |
| Dec 31, 2021 | 5.25 Bn |
| Sep 30, 2021 | 5.29 Bn |